Does LOMITAPIDE Cause Type iia hyperlipidaemia? 59 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Type iia hyperlipidaemia have been filed in association with LOMITAPIDE (Juxtapid). This represents 1.6% of all adverse event reports for LOMITAPIDE.
59
Reports of Type iia hyperlipidaemia with LOMITAPIDE
1.6%
of all LOMITAPIDE reports
55
Deaths
13
Hospitalizations
How Dangerous Is Type iia hyperlipidaemia From LOMITAPIDE?
Of the 59 reports, 55 (93.2%) resulted in death, 13 (22.0%) required hospitalization.
Is Type iia hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOMITAPIDE. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does LOMITAPIDE Cause?
Diarrhoea (1,071)
Therapy cessation (828)
Weight decreased (828)
Nausea (567)
Abdominal pain upper (280)
Flatulence (244)
Abdominal discomfort (228)
Vomiting (211)
Off label use (206)
Fatigue (200)
What Other Drugs Cause Type iia hyperlipidaemia?
ATORVASTATIN (67)
EZETIMIBE (67)
EVOLOCUMAB (66)
ROSUVASTATIN (63)
SIMVASTATIN (63)
LOVASTATIN (56)
PROBUCOL (56)
IMPLITAPIDE (49)
CAFFEINE\PROCAINE (10)
TOCILIZUMAB (8)
Which LOMITAPIDE Alternatives Have Lower Type iia hyperlipidaemia Risk?
LOMITAPIDE vs LOMUSTINE
LOMITAPIDE vs LONAPEGSOMATROPIN-TCGD
LOMITAPIDE vs LONCASTUXIMAB TESIRINE-LPYL
LOMITAPIDE vs LOPERAMIDE
LOMITAPIDE vs LOPINAVIR